Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness
- 31 May 1999
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 82 (5), 497-503
- https://doi.org/10.1016/s1081-1206(10)62728-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Peak expiratory flow variation and bronchial hyperresponsiveness in asthmatic children during periods of antigen avoidance and reexposureAllergy, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Comparison of patients' compliance with prescribed oral and inhaled asthma medicationsArchives of Internal Medicine, 1994
- A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthmaAllergy, 1994
- Peak Expiratory Flow Variability and Bronchial Responsiveness to Methacholine: An Epidemiologic Study in 117 WorkersAmerican Review of Respiratory Disease, 1992
- Measuring compliance with inhaled medication in asthma.Archives of Disease in Childhood, 1992
- A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled FlunisolideChest, 1992
- The Normal Range of Diurnal Changes in Peak Expiratory Flow Rates: Relationship to Symptoms and Respiratory DiseaseAmerican Review of Respiratory Disease, 1991
- How often is medication taken as prescribed? A novel assessment techniquePublished by American Medical Association (AMA) ,1989